Prognostic Value of Non-Invasive Fibrosis Indices Post-Curative Resection in Hepatitis-B-associated Hepatocellular Carcinoma Patients

Ting-Ting Zhang,Si-Si Ye,Jun Liang,Li Bai
DOI: https://doi.org/10.1177/1535370220914252
2020-01-01
Experimental Biology and Medicine
Abstract:The occurrence and acuteness of liver cirrhosis were strongly associated with the hepatocarcinogenesis and the prognosis of hepatocellular carcinoma (HCC). This study compared the prognostic significance of non-invasive fibrosis panel containing 15 indices in hepatitis-B-associated HCC patients’ post-curative resection. Four hundred and five consecutive hepatitis-B-related HCC patients who went through curative hepatectomy were investigated retrospectively. The multivariate Cox proportional hazard model was used to evaluate independent prognostic factors for overall survival (OS). The accuracy in diagnosis of each non-invasive fibrosis index in cirrhosis detection was determined by the area under receiver operating characteristic (AUC) curve. Preoperative AST to platelet ratio index (APRI), Goteburg University Cirrhosis Index (GUCI), and King Score all exhibited a superior performance in diagnosis of cirrhosis detection with AUC > 0.7. APRI and Fibro-α Score were the risk factors that behaved independently in predicting the OS of HCC patients, with an hazard ratio (HR) value of 1.550 (P = 0.012) and 1.420 (P = 0.033), respectively. Preoperative APRI was a relatively accurate predictor of cirrhotic status and prognosis in HCC due to hepatitis-B among the 15 non-invasive fibrosis indices. Impact statement Non-invasive fibrosis indices, according to regular laboratory and clinical data, could be useful in assessing liver fibrosis in chronic hepatitis patients. However, the role of these biomarkers remains unclear in predicting the outcome of HBV-associated HCC in patients. This study was carried out retrospectively and included a relatively large sample size (n = 405) with a heterogeneous population of HBV infected patients and longer duration of prospective follow-up. Our study suggested that APRI and Fibro-α Scores are inversely correlated with overall survival in HBV-associated HCC patients. Meanwhile, GUCI, King Score, and APRI were highly correlated with cirrhosis status. Also, in subgroups of cirrhosis or non-cirrhosis, Fibro-α Scores could differentiate patients with good prognosis from those with poor outcome. This result would aid clinicians in acquiring preventive and therapeutic methods in patients with high risk.
What problem does this paper attempt to address?